Celiac Disease Market Expansion Supported by Rising Awareness Improved Diagnostic Capabilities and Growing Demand for Gluten-Free Diet and Treatment Options

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Celiac Disease Market Size, Share & Trends Analysis Report By Treatments (Infliximab, Larazotide Acetate, Gluten Free Diet), Route Of Administration (Oral And Parenteral), End-Users (Hospitals, Homecare), And Distribution Channels (Hospital Pharmacy, Online Pharmacy, And Retail Pharmacy), Region, Market Outlook And Industry Analysis 2031"

The Global Celiac Disease Market is estimated to reach over USD 1,195.5 Mn by 2031, exhibiting a CAGR of 9.8% during the forecast period.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2874

Celiac disease is an autoimmune disorder characterized by an immune response triggered by the ingestion of gluten, a protein found in grains such as rye, barley, and wheat. This immune reaction damages the lining of the small intestine, leading to the destruction of the villi, which impairs the absorption of essential nutrients, including proteins, fats, carbohydrates, vitamins, and minerals, and can ultimately result in malnutrition.

The Celiac Disease Market is experiencing robust growth, driven by heightened awareness, advancements in diagnostic technologies, and an increasing prevalence of the disease. Key trends in the market include improved diagnosis rates, the expansion of the gluten-free product category, and continued research and development into therapeutic solutions. The primary factors contributing to market growth include the rising incidence of celiac disease, advancements in diagnostic tools, and the growing adoption of gluten-free diets.

However, the market faces several challenges, including limited public awareness, underdiagnosis, and stringent regulatory requirements surrounding gluten-free products. Market segmentation across diagnostic methods, treatment options, end-user groups, and geographical regions allows for the development of tailored strategies and solutions. To address the growing demand and improve patient outcomes, industry leaders have opportunities to introduce innovative diagnostic tools, therapeutic options, and gluten-free products. The Celiac Disease Market is expected to continue expanding as awareness increases and greater emphasis is placed on the management of this chronic autoimmune condition.

List of Prominent Players in the Celiac Disease Market:
• Amgen
• Anokion SA
• BioLineRx Ltd
• ChemoCentryx, Inc
• COUR Pharmaceutical
• F. Hoffmann-La Roche Ltd
• ImmunogenX, LLC
• Innovate Biopharmaceuticals
• Takeda Pharmaceutical Company Limited
• Teva Pharmaceutical Industries Ltd.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-03

Market Dynamics
Drivers:
The growth of the celiac disease market is driven by several key factors. A significant contributor is the increasing prevalence of celiac disease, which is driving higher demand for gluten-free products and therapeutic solutions. Rising consumer awareness about the health risks associated with gluten consumption has become another major driver. Although many individuals with celiac disease receive formal diagnoses, a growing number of undiagnosed individuals are opting for gluten-free diets in response to greater awareness of gluten's adverse health effects. Additionally, advancements in diagnostic techniques are enabling earlier and more accurate detection of the disease, resulting in a larger diagnosed patient population. The expanded availability of gluten-free products in supermarkets and restaurants has further supported market growth, making it easier for patients to adhere to prescribed gluten-free diets.

Challenges:
Despite the market's potential for growth, several challenges may impede its expansion. The high cost of gluten-free products remains a significant barrier, limiting access for many patients and their families. Underdiagnosis continues to be an issue, as there is insufficient awareness and understanding of celiac disease in certain regions. Moreover, stringent food labeling and safety regulations present operational challenges for manufacturers of gluten-free products. Additionally, the limited availability and distribution of gluten-free products in developing countries pose obstacles to market expansion and hinder patient compliance with dietary recommendations.

Regional Trends:
North America currently dominates the celiac disease treatment market, driven by the increasing prevalence of the disease, the presence of key market players, and higher healthcare expenditures in the region. The United States is the largest contributor to market growth within North America. In contrast, the Asia-Pacific celiac disease market is expected to experience rapid growth at a strong compound annual growth rate (CAGR) from 2023 to 2032, supported by growing awareness of the disease and population growth. Within the Asia-Pacific region, China holds the largest market share, while India is experiencing the fastest growth in the celiac disease treatment market.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2874

Recent Developments:
• In June 2021, BioLineRx announced the start of a Phase 2b clinical trial for its flagship drug, BL-7010, as a therapy for celiac disease. The experiment will assess the safety and efficacy of BL-7010 in lowering gluten-induced symptoms and gut inflammation in celiac disease patients.
• In September 2022, ChemoCentryx recently announced encouraging results from a Phase 2 clinical trial of a new medication candidate for celiac disease-associated refractory sprue. The study found that refractory sprue, a severe form of celiac disease, showed encouraging results in terms of symptom reduction and intestinal health.

Segmentation of Celiac Disease Market-
By Treatments-
• Infliximab
• Larazotide Acetate
• Gluten-Free Diet
• Others
By Route of Administration-
• Oral
• Parenteral
By End-Users-
• Hospitals
• Homecare
• Others
By Distribution Channels-
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.